Fortis Healthcare Ltd.

As of June 30, 2026, Fortis Healthcare Ltd. carries a market capitalization of 722.46B, placing it among publicly traded companies globally. Its enterprise value stands at 722.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Fortis Healthcare Ltd.'s next confirmed earnings release is scheduled for November 14, 2026.

As of June 30, 2026, Fortis Healthcare Ltd. has 754.96M shares outstanding.

As of June 30, 2026, Fortis Healthcare Ltd. trades at a trailing price-to-earnings ratio of 68.93.

As of June 30, 2026, Fortis Healthcare Ltd. trades at an EV/EBITDA multiple of 34.30 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 7.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 44.15 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 722.46B versus a market cap of 722.46B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 3.38M in revenue per employee across its workforce of 28,088.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Fortis Healthcare Ltd. recorded 3.08B in income tax expense. That works out to an effective tax rate of 22.36, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 13.78B, leaving 10.48B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Fortis Healthcare Ltd.'s stock has declined approximately 33.81% over the past 52 weeks. The 50-day moving average sits at 856.75, while the 200-day moving average is 901.14.

Over the twelve months ended June 30, 2026, Fortis Healthcare Ltd. generated 95.06B in revenue and converted that into 10.48B in net income, yielding earnings per share of 14.18. EBITDA reached 21.06B, while operating income came in at 16.62B.

Over the twelve months ended June 30, 2026, Fortis Healthcare Ltd. posted a gross margin of 55.95, reflecting its pricing power and cost economics. The operating margin of 17.48 and net profit margin of 11.02 provide insight into operational efficiency.